% | $
Quotes you view appear here for quick access.

Aeterna Zentaris Inc. Message Board

  • qqfranklin qqfranklin Aug 8, 2013 11:22 PM Flag

    This at least is a 100 million cap company

    With one drug in the market, one will summit NDA in weeks, one started phase 3 right after they got money from financing, 4 in phase 2, 1 in phase 1 and many in preclinical, AEZS worth at least 100 million!!!

    I have never seen a biotech company significantly undervalued like this.

    "Following the successfull Phase 3 trial results in AGHD, for which orphan-drug status had been granted by the FDA in 2007, the Company expects to file a new drug application (NDA) in 2Q-2013"

    Simply wait for couple weeks, I believe the market will wake up when the NDA news come out.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.46+0.02(+0.58%)May 24 4:00 PMEDT